Minnetronix Announces Rebrand to Minnetronix Medical
New brand supports the company’s continued investment in technology solutions and development of proprietary therapies.
SAINT PAUL, MINN. (September 10, 2018) – Minnetronix, Inc., a leading medical technology and solutions provider, today announced that it has rebranded as Minnetronix Medical, Inc. The rebrand reflects the company’s continued investment in technology and growth focused on solutions for customers as well as innovative treatments in neurocritical care. As part of the rebranding effort, the company also introduced a new logo, colors, tagline and website all focused on rapidly bringing safe and cost effective medical products to market.
Minnetronix Medical has helped hundreds of medical device companies across the globe bring technologies to market since its founding in 1996. Today, the company is investing further in areas in which it has established significant technical expertise. These investments are strengthening Minnetronix Medical’s industry leading positions in RF Energy, Fluid and Gas Management, Optical Systems, and Stimulation and Active Wearable devices. The investments will expand the company’s ability to deliver state-of-the-art process and technology solutions to medical device companies.
Minnetronix Medical also announced today that it is developing a portfolio of proprietary therapeutic solutions for the Neuro ICU. The company is initially focusing on hemorrhagic stroke patients and has completed a first-in-human study for its Neurapheresis™ Therapy, a breakthrough treatment for post-aneurysmal subarachnoid hemorrhage patients. Neurapheresis™ therapy is a minimally invasive process in which the patient’s Cerebral Spinal Fluid (CSF) is filtered to remove blood and then return the clean CSF to the patient. An extended study is scheduled to begin fall of 2018.
“Minnetronix is growing and broadening its footprint in the healthcare industry. Our new brand better reflects the company we are today and how we are furthering our mission to improve life for patients,” said Rich Nazarian, CEO of Minnetronix. “Over more than two decades we’ve gained a breadth and depth of skill and experience that we’re continuing to use to deliver meaningful solutions to our medical device customers as well as neurocritical care physicians and patients.”
About Minnetronix Medical
Minnetronix Medical is a technology company focused on bringing therapies to market that solve unmet needs. Since 1996, we have been a valued development, manufacturing and technology partner for medical device companies across the globe. We specialize in RF Energy, Fluid and Gas Management, Optical Systems and Stimulation and Active Wearable devices. Today, we are expanding what we do and we’re developing a portfolio of proprietary solutions for the Neuro ICU. www.minnetronixmedical.com
